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Abstract: Bradykinin (BK) and des-Arg9-BK are pro- 
inflammatory mediators acting via B2 (B2R) and B1 (B1R) 
receptors, respectively. We investigated the role of B2R and 
B1R in lipopolysaccharide (LPS)-induced hypothalamo-
pituitary-adrenal (HPA) axis activation in SD rats. LPS 
given intraperitoneally (ip) up-regulated B1R mRNA in 
the hypothalamus, both B1R and B2R were up-regulated 
in pituitary and adrenal glands. Receptor localization 
was performed using immunofluorescence staining. B1R 
was localized in the endothelial cells, nucleus supraop-
ticus (SON), adenohypophysis and adrenal cortex. B2R 
was localized nucleus paraventricularis (PVN) and SON, 
pituitary and adrenal medulla. Blockade of B1R prior to 
LPS further increased ACTH release and blockade of B1R 
1 h after LPS decreased its release. In addition, we evalu-
ated if blockade of central kinin receptors influence the 
LPS-induced stimulation of hypothalamic neurons. Block-
ade of both B1R and B2R reduced the LPS-induced c-Fos 
immunoreactivity in the hypothalamus. Our data demon-
strate that a single injection of LPS induced a differential 
expression pattern of kinin B1R and B2R in the HPA axis. 
The tissue specific cellular localization of these receptors 
indicates that they may play a crucial role in the mainte-
nance of body homeostasis during endotoxemia.
Keywords: B1R; B2R; c-Fos; HPA-axis; receptor localiza-
tion; sepsis.
Introduction
Endotoxemia is a severe stress situation and demands 
necessary adaptive and defensive mechanisms directed 
against the stressor to maintain the body homeostasis. 
Bacterial lipopolysaccharide (LPS) applied intraperito-
neally (ip) mimics sepsis and stimulates the hypothalamo- 
pituitary-adrenal axis (HPA axis) (Leshin and Malven, 
1984; Beishuizen and Thijs, 2003). The HPA axis response 
to LPS is due to the release of cytokines from stimulated 
peripheral immune cells, which in turn stimulate a number 
of physiological systems at different levels of the HPA axis 
(Bertok, 1998). During sepsis, the major hypothalamic 
component involves corticotropin-releasing hormone 
(CRF), which is released into the pituitary portal circula-
tion and drives the release of ACTH from the anterior pitui-
tary. ACTH, in turn stimulates the synthesis and secretion 
of cortisol/corticosterone (CORT) from the adrenal cortex. 
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CORT is a pluripotent hormone acting on multiple tissues 
to regulate numerous aspects of metabolism, growth and 
physiological functions, which makes it essential for sur-
vival in critical illness, as in septic shock (Munck and 
Guyre, 1986). Systemic LPS injection also stimulates the 
synthesis and secretion of aldosterone (ALDO) from the 
adrenal glands (Sanchez-Lemus et al., 2008).
Bradykinin (BK) and des-Arg9-BK are biologically 
active peptides that act on type 2 (B2R) and type 1 (B1R) 
receptors, respectively. They produce a variety of patho-
physiological responses, including pain, hyperalgesia, 
increased vascular permeability and vasorelaxation, thus 
implicating them in inflammatory and cardiovascular dis-
eases (Bhoola et  al., 1992; Marceau et  al., 1997; Couture 
et al., 2001; Marceau and Regoli, 2004). These receptors 
differ in their expression pattern: the B2R is constitutively 
expressed, whereas the B1R is weakly expressed in most 
tissues under physiological conditions but strongly up-
regulated during tissue injury, inflammation and some 
pathological conditions (Marceau and Bachvarov, 1998; 
Couture and Lindsay, 2000; Leeb-Lundberg et al., 2005). 
Up-regulation of B1R during LPS-induced endotoxemia 
has been shown in different organs such as porcine arte-
rial smooth muscle cells (Schremmer-Danninger et  al., 
1996), mouse heart (McLean et  al., 1999) and mouse 
kidney (Seguin et  al., 2008), indicating a crucial role in 
the modulation of organ function and ultimately in the 
maintenance of body homeostasis in endotoxemia. This 
was confirmed by studies performed in B1R transgenic 
rats (Merino et  al., 2008) and B1R-KO mice (Pesquero 
et al., 2000) in our laboratory. In our previous studies, we 
demonstrated a differential regulation of B1R and B2R in 
the HPA axis in different animal disease models such as in 
spontaneously hypertensive rats (Qadri et al., 2002, 2003); 
and in rat models of type 1 and type 2 diabetes, such as 
streptozotocin-induced and Zucker diabetic fatty rats, 
respectively (Qadri et al., 2004).
To our knowledge, the expression patterns and poten-
tial functions of kinin B1R and B2R in the HPA axis during 
LPS-induced endotoxemia have previously not been 
shown. Therefore, the main aim of the present study was 
to investigate the role of kinins in LPS-induced HPA axis 
activation. First, we studied the effect of a single injection 
of LPS given ip on the expression pattern of B1R and B2R 
at mRNA level in the hypothalamus, pituitary and adrenal 
glands (neuroendocrine pathway), and also in dorsal and 
ventral medulla of the brainstem (autonomic/ sympathetic 
pathway). Both pathways are important in the mainte-
nance of body homeostasis. As alterations occur in imme-
diate hormonal release and gene expression early in the 
course of sepsis, all analyses were carried out at 3 different 
time points, i.e. 1, 3 and 6 h after a single LPS ip adminis-
tration. Second, we characterized the immunohistological 
and cellular localization of B1R and B2R in the HPA axis 
after LPS injection. In addition, the role of kinin recep-
tors on LPS-induced hormonal secretion into the systemic 
blood was evaluated.
Results
Effect of LPS given ip on B1R and B2R mRNA 
levels in the HPA axis
Figure 1 shows LPS-induced B1R and B2R mRNA levels 
in the HPA axis. Compared to vehicle-treated rats, LPS 
induced a significant and time-dependent increase in 
B1R mRNA in the hypothalamus, without affecting the 
B2R mRNA levels [(A) and (B) left panel]. In the pituitary 
gland, LPS induced a marked increase in both B1R and 
B2R mRNA levels after 1  h and the expression remained 
up regulated all the time [(A) and (B) middle panel]. More-
over, there was a time-dependent and significant increase 
in B1R and B2R mRNA at 3 and 6 h after systemic LPS [(A) 
and (B) right panel]. An additional quantitative real-time 
PCR analysis was performed using cDNA from 3 h LPS (ip) 
animals in hypothalamus, pituitary and adrenal glands 
to give more credibility to the data. The seim-quantitative 
and quantitative real-time data was comparable (Supple-
mental Figure 1).
LPS-induced B1R and B2R mRNA levels were also 
measured in the brainstem. Only 6 h after LPS injection, 
a significant increase in the B1R mRNA level was found 
both in dorsal medulla (DM) and ventral medulla (VM) of 
the brainstem, but B2R mRNA levels remained unchanged 
(Supplemental Figure 2).
LPS-induced immunofluorescence 
 localization of B1R and B2R in the HPA axis
Conformation of antibody specificity
Next we analyzed the protein expression of B1R and 
B2R in the HPA axis after LPS stimulation. To this 
purpose, we first verified the specificity of the antibod-
ies. Very often, unspecific immunoreactivity of antibod-
ies directed against G protein-coupled peptide receptors 
is found (Beck and Lock, 2014; Day, 2014). Therefore, we 
used B1R and B2R knock-out (KO) mouse tissue to verify 
the specificity of antibodies against B1R (developed by 
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Dr. Leeb-Lundberg, Sweden) and B2R (commercially avail-
able from US  Biologicals, USA), respectively. To verify the 
antibody against B1R, we used kidney tissue from adult 
male wild type (WT, C57BL/6 strain), B1R-KO, B2R-KO 
mice, both animals on C57BL/6 genetic background. From 
these mice, kidneys were removed 3  h after vehicle or 
LPS ip injection. To verify the specificity of B2R antibody, 
adrenal glands from untreated mice (described as above) 
were used. Five μm thick paraffin sections of kidney and 
adrenal glands were processed to stain B1R or B2R using 
immunofluorescence, respectively (Supplemental Figures 
3 and 4). Before processing the tissue for immunofluo-
rescence staining, real-time PCR was performed in snap 
frozen kidney or adrenal gland to confirm that B1R or B2R 
mRNA is absent in our KO mice, respectively (data not 
shown).
Localization of B1R and B2R in the hypothalamic SON
Figure 2 shows representative fluorescent microscopic 
images of SON in vehicle- and LPS-treated SD rats. 
 Compared to vehicle treatment, LPS induced a strong up 
regulation of B1R in neurons located in the SON as well as 
in endothelial cells of the cerebral capillaries [(A) and (B), 
respectively]. The B2R immunopositive signal was detected 
in SON in both control and LPS-treated rats; however, 
there was no significant difference between them. Fur-
thermore, there was no detectable B2R expression in the 
cerebral capillaries in vehicle- or LPS-treated rats [(C) and 
(D), respectively].
Localization of B1R and B2R in the hypothalamic PVN
Figure 3 shows representative fluorescent microscopic 
images of PVN in vehicle- and LPS-treated SD rats. There 
was no immunopositive signal for B1R in PVN, however, 
there was a weak signal in the basal region of the ependy-
mal cell lining of the third ventricle in LPS-treated PVN 
[(A) and (B), respectively]. On the other hand, a B2R 
immunopositive signal was detected in PVN of both 
control and LPS-treated rats, however, there was no sig-
nificant difference in B2R signal between them [(C) and 
(D), respectively].
Localization of B1R and B2R in the pituitary gland
Figure 4 shows representative fluorescent microscopic 
images of pituitary gland of vehicle- and LPS-treated SD 
rats. Compared to vehicle-treated rats, B1R in LPS-treated 
rats was highly up regulated in adenohypophysis, whereas 
a very weak signal was found in neurohypophysis and no 
signal was found in pars intermedia. Interestingly, B1R 
was also up regulated in the endothelial cells of the capil-
laries found in all parts of the gland (B).
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Figure 1: RT-PCR analysis of mRNA levels.
(A) Kinin B1R (upper panel) and (B) B2R (lower panel) mRNA levels normalized to β-actin mRNA in the hypothalamus, pituitary and adrenal 
glands 1, 3 and 6 h after a single injection of LPS (5 mg/kg, ip) or 0.9% saline which served as vehicle control in SD rats, as analyzed by 
RT-PCR. Values are mean±SEM (n = 4 each group, treatment and each time point). *p < 0.05, **p < 0.01, ***p < 0.001 vs. vehicle. n = 4/group/time 
point.
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Figure 2: Immunofluorescence localization of kinin B1R and B2R in hypothalamic supraoptic nucleus (SON) from LPS (ip)-treated or vehicle-
treated SD rats.
Hypothalamic 5 μm thick paraffin sections were labeled with primary antibodies against B1R (1:200) [upper panel (A) and (B)] or B2R  
(1:200, US Biologicals) [lower panel (C) and (D)], followed by anti-rabbit Cy3-conjugated secondary antibodies. DAPI stained nuclei (blue). 
Green/yellow dots are auto-fluorescent red blood cells. n = 3/group and 4–5 Sections from each animal were stained for kinin receptors.
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Figure 3: Immunofluorescence localization of kinin B1R and B2R in hypothalamic paraventricular nucleus (PVN) from LPS- or vehicle-treated 
(ip) SD rats.
Hypothalamic 5 μm thick paraffin sections were labeled with primary antibodies against B1R (1:200) [upper panel (A) and (B)] or B2R  
(1:200, US Biologicals) [lower panel (C) and (D)], followed by anti-rabbit Cy3-conjugated secondary antibodies. DAPI stained nuclei (blue). 
Green/yellow dots are auto-fluorescent red blood cells. n = 3/group and 4–5 Sections from each animal were stained for kinin receptors. 
PVN, Nucleus paraventricularis; 3 V, brain third ventricle.
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Under physiological conditions, B2R is constitutively 
expressed in almost all tissue. In the pituitary, we observed 
that B2R was localized not only in the cytoplasm but also 
in the nucleus of the cells located in the adeno and neuro-
hypophysis, whereas this receptor was localized primarily 
in the cytoplasm of pars intermedia cells (C). Following 
LPS-treatment, there was an increase in B2R expression 
both in adeno and neurohypophsis, where as a reduced 
expression occured in pars intermedia (D).
Localization of B1R and B2R in the adrenal gland
Figure 5 shows representative fluorescent microscopic 
images of adrenal glands from vehicle- and LPS-treated 
SD rats. There was clear and differential expression of 
B1R and B2R following LPS stimulation. LPS-treatment 
induced an increase in B1R in the adrenal cortex as com-
pared to vehicle (A and B). Interestingly, there was a dif-
ferential expression in the adrenal cortex: very high signal 
in zona glomerulosa, weak signal in zona fasciculata and 
no signal in zona reticularis. As we found in the pituitary 
gland, the B1R expression in the blood vessels around the 
adrenal gland was also up regulated. B2R were highly up 
regulated in adrenal medulla following LPS treatment vs. 
control (C and D).
Effect of B1R on LPS-induced plasma ACTH, 
CORT and ALDO levels
In order to evaluate the importance of the increased 
LPS-induced B1R expression, we inhibited the B1R 
centrally and assessed the effect on HPA activation. 
Compared to vehicle treated rats, LPS ip induced a sig-
nificant and time-dependent increase in plasma ACTH, 
CORT and ALDO levels (Figure 6). The maximum plasma 
levels were observed at 1 h following LPS and decreased 
gradually with time. Pretreatment of rats with B1R 
antagonist R-715 (icv) 10 min prior to LPS ip administra-
tion further increased the plasma ACTH level without 
affecting either CORT or ALDO [(A) left panel]. On the 
other hand, icv application of the specific B1R antago-
nist R-715 for 1 h after LPS ip administration significantly 
decreased plasma ACTH levels without affecting CORT 
or ALDO plasma concentrations [(B) right panel].
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Figure 4: Immunofluorescence localization of kinin B1R and B2R in pituitary glands from LPS (ip)-treated or vehicle-treated SD rats.
Three μm thick paraffin sections of pituitary were labeled with primary antibodies against B1R (1:200) [upper panel (A) and (B)] or B2R 
(1:200, US Biologicals) [lower panel (C) and (D)], followed by anti-rabbit Cy3-conjugated secondary antibodies. DAPI stained nuclei (blue). 
Green/yellow dots are auto-fluorescent red blood cells. n = 3/group and 4–5 Sections from each animal were stained for kinin receptors.
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Effect of B1R and B2R on LPS-induced c-Fos 
expression in the subfornical organ and 
hypothalamus
As a second parameter of HPA axis activation, we studied 
the LPS-induced activation of neurons in the hypothala-
mus by c-Fos staining after inhibition of B1R and B2R. The 
expression of c-Fos protein in the subfornical organ (SFO) 
and hypothalamus was undetectable in rats treated with 
vehicle [Figure 7 (A)]. Ninety minutes following LPS injec-
tion, there was a marked increase in c-Fos immunoreac-
tivity in SFO and within a set of hypothalamic structures. 
Very high density of c-Fos immunolabelled cells were 
found in the hypothalamic supraoptic nucleus (SON) 
and paraventricular nucleus (PVN) [Figure 7 (B)]. In pos-
terior hypothalamic areas, LPS treatment had no effect 
on c-Fos expression (data not shown). Few and scattered 
c-Fos immunopositive cells were recognized in the lateral 
hypothalamus. When compared to LPS-treatment alone, 
pretreatment of rats with the B1R antagonist R-715 prior 
to LPS highly reduced the c-Fos expression in SFO and 
PVN and weakly in SON [Figure 7 (C)] middle panel). 
On the other hand, the specific B2R antagonist Hoe 140, 
also given icv prior to LPS, weakly reduced the c-Fos 
expression in SFO (mainly upper part of it), SON and PVN 
[Figure 7 (D)].
Discussion
Induction of kinin B1R and B2R in 
 hypothalamus in response to systemic LPS 
challenge
We have shown an acute up regulation of B1R at mRNA 
and protein levels in the hypothalamus after a single injec-
tion of LPS applied systemically. The mRNA and protein 
expression of B1R was correlated with the induction of 
LPS-induced c-Fos expression in hypothalamic SON. The 
SON together with hypothalamic PVN are the key site for 
integrating neuroendocrine, autonomic and behavioral 
adjustments to diverse homeostatic challenges, includ-
ing patho-physiological (e.g. inflammation) and emo-
tional stressors (e.g. restraint) (Sawchenko, 1991). It has 
been shown by many authors that concomitant with an 
increase in plasma ACTH, LPS administration (ip or iv) 
resulted in an activation of neurons in the hypothalamic 
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Figure 5: Immunofluorescence localization of kinin B1R and B2R in adrenal glands from LPS (ip)-treated or vehicle-treated SD rats.
Adrenal 5 μm thick paraffin sections were labeled with primary antibodies against B1R (1:200) [upper panel (A) and (B)] or B2R  
(1:200, US Biologicals) [lower panel (C) and (D)], followed by anti-rabbit Cy3-conjugated secondary antibodies. DAPI stained nuclei (blue). 
Green/yellow dots are auto-fluorescent red blood cells. n = 3/group and 4–5 Sections from each animal were stained for kinin receptors.
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Figure 6: (A) Plasma ACTH, CORT and ALDO levels in basal, 1, 3 and 6 h after a single injection of LPS (5 mg/kg, ip) or vehicle (0.9% saline, 
ip) and pre-treatment with kinin B1R antagonist R-715 (1 μg/10 μl, icv) 10 min prior to LPS (ip). (B) Plasma ACTH, CORT and ALDO levels in 
basal, 1, 3 and 6 h after a single injection of LPS (5 mg/kg, ip) or vehicle (0.9% saline, ip) and treatment with kinin B1R antagonist R-715  
(1 μg/10 μl, icv) 1 h after LPS (ip) injection. n = 4–6/group. ACTH, Adrenocorticotropine releasing hormone; CORT, corticosterone; ALDO, 
aldosterone; LPS, bacterial lipopolysaccharide; ip, intraperitoneal; icv, intracerebroventricularly.
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Figure 7: Immunohistochemical localization of c-Fos immunoreactivity in hypothalamic supraopticus and paraventricular nuclei.
Analysis was performed at 90 min after a single LPS injection (5 mg/kg, ip) (B); effect of blockade of B1R with R-715 (1 μg/10 μl, icv) 10 min 
prior to LPS (ip) injection (C) and effect of blockade of B2R with Hoe 140 (1 μg/10 μl, icv) 10 min prior to LPS (ip) (D) and compared with 
vehicle-treated control rats (A). n = 3/group. LPS, Bacterial lipopolysaccharide; SON, hypothalamic supraoptic nucleus; PVN, hypothalamic 
paraventricular nucleus; icv, intracerebroventricular; ip, intraperitoneal.
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SON and PVN as indicated by the enhanced expression 
c-Fos (Hare et al., 1995; Takemura et al., 1997; Reyes et al., 
2003; Xia and Krukoff, 2003).
In the current study, besides hypothalamic SON/PVN, 
we also observed LPS-induced c-Fos expression in the sub-
fornical organ (SFO). SFO is a highly vascularized region 
and is devoid of blood-brain-barrier and it has direct con-
nections to hypothalamic SON/PVN: It is established that 
SFO co-ordinates various physiological systems involved 
in the maintenance of body fluid homeostasis (Miselis 
1981; Lind et al., 1982; Johnson et al., 1996). It ‘senses’ the 
changes occurring in systemic humoral factors induced 
by, for example, LPS and conducts these information to 
the hypothalamic SON and PVN. Accordingly, ablation of 
SFO significantly reduced LPS-induced c-Fos expression 
in SON and PVN, and also affected neuro-hormonal secre-
tion (Borges and da Rocha, 2006). Due to its location in the 
brain, substances have direct access to SFO when injected 
into the lateral brain ventricle. In the present study, pre-
treatment of rats with kinin B1R or B2R antagonists given 
into the lateral brain ventricle reduced the LPS-induced 
c-Fos expression not only in SFO but also in hypotha-
lamic SON and PVN. It is not fully clarified, whether 
LPS directly binds to its receptors in SFO or affects it via 
pro- inflammatory cytokines such as IL-1, IL-6 or TNFα or 
prostaglandins. There is, however, limited evidence that 
SFO possess receptors for cytokines and prostaglandins 
(Cartmell et al., 1999; Zhang and Rivest, 1999, 2000). Our 
present data allow us to suggest that during endotox-
emia pro-inflammatory factors may bind to their recep-
tors in SFO and activate ‘kininergic’ pathway(s) leading 
to the hypothalamus. The increase in B1R expression in 
the hypothalamus may function as a mediator between 
systemic endotoxin and the initial defense reaction of the 
CNS (activation of HPA axis) to release stress hormones 
into portal circulation of pituitary gland. Our present data 
is in line with the data published by Coelho et al. (1997), 
irrespective of the route of LPS application, who have 
demonstrated kinin B1R induction plays an important role 
in LPS-induced febrile response.
Besides hypothalamus, brain stem regions such 
as dorsal (DM) and ventral (VM) medulla play impor-
tant roles in maintaining vascular homeostasis. There 
are ascending noradrenergic projections from DM and 
VM to hypothalamic PVN (Sawchenko and Swanson, 
1981), which were activated upon systemic LPS chal-
lenge  (Cunningham et  al., 1994; Gaykema et  al., 2007; 
 Bienkowski and Rinaman, 2008). We found an increase in 
B1R mRNA levels both in DM and VM 6 h after LPS injec-
tion and no change in B2R mRNA levels. This shows a 
low susceptibility of the brainstem regions to acute LPS 
when compared to hypothalamus, where B1R was highly 
expressed directly after systemic LPS. This may affirm that 
‘kininergic’ action of the hypothalamus is crucial to sys-
temic LPS exposure and the medullary regions (DM and 
VM) play less important roles during acute endotoxemia.
Induction and differential localization of 
kinin B1R and B2R in pituitary in response to 
systemic LPS challenge
Systemic LPS can directly or indirectly (via cytokines) 
influence the pituitary gland, since part of the gland lacks 
a blood-brain barrier. In the present study, a high suscep-
tibility of pituitary gland to systemic LPS was observed. 
A significant elevation of both B1R and B2R mRNA and 
protein levels were found at 1 h after LPS exposure. Our 
finding that systemic LPS induced a specific and differ-
ential expression of B1R and B2R in defined parts of this 
endocrine gland suggests a modulatory role of kinins in 
synthesis/release of neuro hormones.
The maximal increase in ACTH release was observed 
at 1 h following LPS ip. Interestingly, the pretreatment of 
rats with the B1R antagonist (icv) prior to LPS exposure 
resulted in a significant increase in ACTH release com-
pared to systemic LPS. A possible explanation could be 
that the further increase in ACTH release could be due to 
the endogenous central kinin B2R. Madeddu et al. (1992) 
have demonstrated that BK when applied icv increased 
the concentration of plasma ACTH via B2R. On the other 
hand, blocking of ‘induced B1R’ centrally during endotox-
emia inhibited the neuronal pathway leading to SON/PVN 
and hence decreased the release of ACTH from pituitary 
gland. This could be a possible explanation for the reduc-
tion in plasma ACTH concentration when B1R antagonist 
was applied (icv) 1  h after the LPS ip, as found in our 
current data. Interestingly, we observed a positive immu-
nostaining for B2R not only in cytoplasm but also in the 
nuclei of pituitary cells found mainly in the neurohypoph-
ysis and it seems that systemic LPS increased the nuclear 
expression of B2R. Further investigations are necessary 
to elucidate the precise function(s) of nuclear B2R in the 
pituitary gland during endotoxemia.
Induction and differential localization of 
B1R and B2R in adrenal gland in response to 
systemic LPS challenge
In the present study, adrenal glands responded with a 
different time course to systemic LPS from hypothalamus 
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and pituitary gland. We observed the maximum increase 
of B1R mRNA at 6 h and of B2R at 3 h after LPS. Interest-
ingly, there was differential cellular localization of B1R 
and B2R in adrenal gland indicating differential regula-
tion of CORT, ALDO and/or monoamines. A higher B1R 
immunofluorescent signal was observed in zona glomeru-
losa compared to CORT secreting zona fasciculata. On the 
bases of cellular localization in the adrenal cortex, it can 
be postulated that LPS-induced up-regulation of B1R may 
influence the secretion of both ALDO and CORT independ-
ent of central influence, since B1R antagonist given icv did 
not change the levels of these hormones. The most strik-
ing and interesting finding was that the adrenal medulla 
did not show B1R immunostaining. On the contrary, when 
compared to control, systemic LPS induced an up-regu-
lation of B2R significantly in adrenal medulla. This may 
confirm our previous work where we showed increased 
endogenous B2R in the adrenal medulla from spontane-
ously hypertensive rats (Qadri et al., 2003, 2004). LPS also 
induced low levels of B2R expression in adrenal cortex 
compared to medullary expression. This may suggest that 
during endotoxemia induced B2R in adrenal cortex may 
also affect ALDO and CORT secretion (Rosolowsky and 
Campbell, 1992), whereas medullary B2Rs are crucial for 
monoaminergic neurotransmitter release and/or synthe-
sis. Previously, BK via B2R has been shown to induce an 
increase in norepinephrine release from chromaffin and 
PC12 cells in vitro (Dendorfer and Dominiak, 1995; Dendor-
fer et  al., 1996). Endotoxemia is known to be associated 
with increased sympathetic nerve activity and deple-
tion of norepinephrine and epinephrine contents in the 
adrenal gland and in sympathetically innervated tissues 
(Wang et  al., 2000). LPS-induced pro-inflammatory 
cytokines or LPS may directly affect B2R expression in 
the adrenal medulla resulting in catecholamine release. 
Since systemic LPS resulted in hypotension, it is conceiv-
able that catecholamine released by adrenal gland after 
B2R activation counter-regulate the hypotension during 
endotoxemia.
Induction of endothelial B1R in response to 
systemic LPS challenge
Activation of kinin B1R and B2R leads to vascular dilata-
tion via release of endothelial factors and could provide 
beneficial effects in cardiovascular disease therapy. On 
the other hand, induction of B1R activates inducible nitric 
oxide and NADPH oxidase, which are associated with vas-
cular inflammation, increased permeability and cause 
endothelial dysfunction. A number of in vitro and in vivo 
studies have been published demonstrating the signifi-
cance of B1R induction after various manipulations which 
causes severe diseases in animal models (Calixto et  al., 
2004, Duchene and Ahluwalia, 2009; Viel and Buck, 2011; 
Girolami et al., 2014; Bhat et al., 2014). Overexpression of 
B1R in endothelial cells increased the susceptibility and 
its gene deletion attenuated the LPS-induced endotoxic 
shock in rodents (Pesquero et al., 2000; Cayla et al., 2007; 
Merino et al., 2008). In the current study, upon systemic 
LPS, we observed an up-regulation of B1R expression in 
the endothelial cells in brain capillaries and in pituitary 
and adrenal glands. Further investigations are needed 
to find out, whether the upregulaton of B1R in endothe-
lium is beneficial or deleterious to the animals during 
endotoxemia.
In conclusion, our current data demonstrated that 
systemic injection of LPS induced an early induction/up-
regulation of kinin B1R in the hypothalamus, pituitary 
and adrenal glands. B1R cellular expression was tissue-
specific and could modulate the neuronal functions, since 
blockade of B1R centrally reduced the neuronal c-Fos 
expression in the hypothalamus and affected the LPS-
induced ACTH release. The tissue-specific up-regulation 
of B2R in pituitary and adrenal glands indicate their sig-
nificance in release of hormones. The specific cellular 
localization of B1R and B2R in HPA axis will help us to 
study the role played by these receptors and their signifi-
cance during endotoxemia.
Materials and methods
Animals
Male Sprague-Dawley (SD) rats (10–12 weeks) were purchased from 
Charles River (Sulzfeld, Germany). They were kept under controlled 
conditions with a 12-h light/dark cycle and had free access to stand-
ard rat diet and water. The experiments were conducted in accord-
ance with the NIH Guide for the care and use of laboratory animals. 
Experimental protocols were approved by the state Government of 
Germany and also by the local Ethics Committee of the University of 
Lübeck, Germany.
Experimental protocols
The following experimental protocols were designed:
Determination of B1R and B2R expression at the mRNA level 
 following injection of LPS: Rats were divided into two groups. Each 
rat from group 1 received a single injection of vehicle (0.9% saline, 
ip) and served as control, rats of group 2 received a single injection 
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of LPS (5 mg/kg body weight, ip) (Escherichia coli serotype 055:B5; 
Sigma, Taufkirchen-München,  Germany). Rats were sacrificed 1, 3 
and 6 h following ip  injection (n = 4/group and time point). Pituitary 
and adrenal glands were removed and frozen in isopentane kept 
on dry ice (-40°C).  Hypothalamic block consisting of nucleus para-
ventricularis (PVN) and supraoptic nucleus (SON), part of lateral 
hypothalamus and posterior hypothalamus was dissected according 
to the method described by  Palkovits and Brownstein (1988). Brain-
stem was removed en bloc under the posterior half of the cerebellum. 
It was divided into dorsal (DM) and ventral medulla (VM). The DM 
consisted of area posterema (AP), nucleus of the solitary tract (NTS) 
and core of the vagus and the VM consisted of caudo-ventrolateral 
medulla (CVLM),  rostro-ventrolateral medulla (RVLM) including 
reticular nuclei. All tissue samples were frozen immediately and 
stored at -80°C until further use.
RNA isolation, cDNA synthesis and semi-quantitative RT-PCR 
analysis
The techniques used here were described earlier in detail (Qadri et al., 
2002; Häuser et al., 2005). In short, hypothalamus, DM, VM, pituitary 
and adrenal glands were homogenized in the presence of guanidinium 
isothiocyanate. Total RNA was isolated, first strand cDNA was synthe-
sized from 1 μg of total RNA. Specific B1R, B2R and β-actin sense and 
antisense oligonucleotide primers were designed based on their pub-
lished cDNA sequences. The following primers were used: fw-GCATC-
CCCACATTCCTTCTA and rev-AAGAAGTGGTAAGGGCACCA for B1R (acc. 
#AJ132230, amplicon size 301bp); fw-CTTGGGTGAGCTCAGTGTCA and 
rev-AG GGGCAGACATTTGAAGG for B2R (acc. #M59967, amplicon size 
299bp) and fw-GTGGGTATGGGTCAGAAGGA and rev-AGCGCGTAAC-
CCTCATAGAT for β-actin (acc. #NM-031144, amplicon size 308bp). 
Semi-quantitative RT-PCR was performed using 3 μl of undiluted cDNA 
for kinin receptors and 3 μl of diluted cDNA (1:100) for β-actin, which 
served as house keeping gene.
Because of the high sensitivity of the PCR, several control exper-
iments were performed to exclude false positive results as described 
previously (Qadri et al., 2002; Häuser et al., 2005). In brief, to moni-
tor possible contamination with genomic DNA, a control RT-PCR was 
performed without the reverse transcriptase. PCR cycle numbers 
for each gene were optimized by kinetic analysis to ensure that the 
amplification is within the exponential phase of the PCR. To verify 
the specificity of the PCR, restriction analysis of amplicons was per-
formed by incubating the amplicons with specific restriction enzyme 
which digested the PCR product into two distinct fragments (data not 
shown).
Immunohistological localization of LPS-induced B1R and B2R recep-
tors in the HPA axis: Rats were divided into two groups. Each rat 
from group 1 received a single injection of vehicle (0.9% saline, ip, 
n = 3) and served as control and from group 2 received a single injec-
tion of LPS (5 mg/kg body weight, ip, n = 3). Rats were sacrificed 3 h 
after LPS injection (n = 3/group). Whole brain, pituitary and adre-
nal glands were removed and fixed in 4% phosphate buffered PFA, 
processed and embedded in paraffin blocks. Five μm sections were 
cut (Microm HM355 S, MICROM International GmbH, Walldorf, 
 Germany), deparaffinized, rehydrated and processed for immuno-
staining using a polyclonal antibody raised against human B1R 
(kindly donated by Dr. L.M. Fredrik Leeb-Lundberg), which cross-
react with mouse and rat tissue (1:200) (Sandén and Leeb-Lundberg, 
2013) and commercial available antibody against B2R (1:200) (US Bio-
logicals, Biomol GmbH, Hamburg, Germany; catalog #B2676-02 and 
Lot #L61017766). Both B1R and B2R antibodies were tested for their 
specificity using B1R and B2R knock-out mouse tissue, respectively 
(Boyce et al., 1996; Pesquero et al., 2000).  Secondary anti-rabbit anti-
body was conjugated to Cy3 (1:300,  Jackson  Immunoresearch Europe 
Ltd, Suffolk, UK). Sections were mounted using Vectashield mount-
ing medium containing DAPI (Vector Laboratories, Axxora, Lörach, 
 Germany).  Microscopic images were taken using the fluorescence 
microscope ‘Keyence, BZ-9000’ (Keyence Deutschland GmbH, Neu-
Isenburg, Germany).
We used 4–5 Sections from each brain, pituitary and adre-
nal glands from vehicle- or LPS-treated rats. Brain sections were 
used comprising of hypothalamic PVN and SON. Care was taken in 
choosing the sections from pituitary and adrenal glands, compris-
ing adenohypophysis, neurohypophysis and pars intermedia in the 
pituitary, and cortex and medulla in adrenal glands.
Determination of the involvement of central B1R in LPS (ip)-induced 
ACTH, CORT and ALDO release into the blood circulation
Experimental design 1
Intracerebroventricular (icv), intraperitoneal (ip) and intrafemoral 
catheters were implanted chronically in rats under anesthesia as 
described previously in detail (Qadri et al., 1991 and 1993). Experi-
ments were performed between 7 am and 1  pm in conscious and 
freely moving and unrestraint rats. Rats were randomly allocated 
to three groups. Group 1 received vehicle (0.9% saline, ip) and 
served as control. Group 2 (n = 4) received a single injection of LPS 
(5 mg/kg body weight, ip). The animals of group 3 (n = 4) received 
10 min prior to LPS (ip), R-715, a specific B1R antagonist (1 μg/10 
μl vehicle, icv) (R-715 was kindly donated by Dr.  D.  Regoli to Dr. 
A. Dendorfer). Blood samples each 1  ml were collected from the 
femoral artery 1, 3 and 6 h after LPS injection. The blood volume 
was substituted with 1 ml 0.9% saline.
Experimental design 2
All experiments in this protocol were done as described above except 
that the B1R antagonist (R-715, 1 μg/10 μl vehicle, icv) was given 1 h 
after the LPS (ip) injection. Blood samples were collected at 1, 3 and 
6  h to measure plasma ACTH, CORT and ALDO (n = 4). The blood 
volume was substituted with 1 ml 0.9% saline. The plasma levels of 
ACTH, CORT and ALDO were measured using commercially available 
RIA kits (Linco Research Inc., MO, USA).
Determination of the effect of B1R and B2R on LPS-induced c-Fos 
expression in the hypothalamus: Several studies have demon-
strated that the ‘immediate early gene’, c-fos is expressed in neurons 
whose activity is strongly stimulated by different challenges includ-
ing systemic LPS-induced inflammation. Using immunocytochemis-
try the protein c-Fos can be localized in defined brain regions (Wan 
et  al., 1994; Sagar et  al., 1995). We used this method to determine 
the effect of B1R and B2R receptor on LPS-induced c-Fos expression 
in hypothalamus. Anesthetized animals were placed in a stereotaxic 
frame for the implantation of a chronic icv cannula (Qadri et  al., 
1991). In brief, a polypropylene cannula was inserted into the left lat-
eral brain ventricle with the following coordinates: 0.6  mm caudal 
to bregma 1.3 mm lateral to the left side of the midline and 5.0 mm 
ventral from the dural surface according to ‘The Rat Brain in Stere-
otaxic Coordinates’ by G. Paxinos and C. Watson (1986). A chronic 
catheter was inserted intraperitoneal for the administration of LPS 
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or vehicle. Rats were housed individually for a 7 day post-operative 
recovery period. To avoid unspecific stress-induced c-Fos expres-
sion, animals were handled by the same experimenter every day for 
10–15 min before the implantation of chronic catheters and until the 
experiment was performed.
Experimental design
Experiments were performed between 7 am and 1 pm in conscious 
freely moving and unrestraint rats (n = 4/group). Group 1 received LPS 
(5 mg/kg body weight, ip). Group 2 received vehicle (0.9% saline ip) 
and served as control. The animals of group 3 received 10 min prior 
to LPS (ip) R-715, the specific B1R antagonist (R-715, 1 μg/10 μl vehicle, 
icv). The animals of group 4 were pretreated with Hoe 140, the spe-
cific B2R antagonist (Tocris, Bristol, UK) (1 μg/10 μl vehicle, icv) prior 
to LPS (ip). Ninety minutes after LPS injection, rats were anesthe-
tized with sodium pentobarbital and perfused intracardial with 0.9% 
saline containing heparin and then with 4% phosphate buffered PFA. 
Brains were removed, post fixed overnight in the same fixative and 
incubated for approximately 72 h in 30% sucrose at 4°C for cryopro-
tection. Coronal sections (50 μm) were cut at -20°C (Leica CM3050S, 
Wetzler, Germany) and transferred into PBS at room temperature. 
The free-floating brain sections were processed for immunocyto-
chemistry using the conventional avidin-biotin complex peroxidase 
reaction as recommended by the manufacturer (Vector Laboratories, 
Axxora, Lörach, Germany, UK). The dilution of primary anti c-Fos 
antibody was 1:3000 (BD Transduction Laboratories, Lexington, 
USA). Sections were mounted onto Super-Frost® slides (Menzel-
Gläser, Braunschweig, Germany), dehydrated in alcohol, cleared in 
xylene and cover-slipped with the mounting medium Eukitt (Sigma-
Aldrich, Taufkirchen-Münschen, Germany).
Statistical analysis
Data are expressed as mean±SEM. Differences in the expression of 
kinin receptors in HPA axis between vehicle treated control and LPS 
treated rats at each time point were evaluated by Student’s t-test and 
(where necessary) one-way ANOVA followed by Bonferroni post-hoc 
test using the computer program GraphPad Prism (GraphPad Prism 
Software Inc). A value of p < 0.05 indicated significant differences.
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